Study on the efficacy of omalizumab injection in allergic diseases and nursing experience / 中国实用护理杂志

ABSTRACT

Objective:To guide the improvement of related nursing strategies by observing the therapeutic effect of omalizumab on patients with allergic diseases and summarizing the nursing work.Methods:Collected the medical history, the total serum IgE level before the start of treatment, clinical symptoms Visual Analogue Scale (VAS) questionnaire, and the Patient Global Impression of Change (PGIC) after treatment of 108 patients with allergic diseases who received omalizumab in the Allergy Department of Beijing Tongren Hospital from October 2018 to September 2020. The clinical efficacy was mainly evaluated based on the VAS scores of lung and nasal symptoms before and after treatment.Results:Omalizumab injection could significantly improve nasal and pulmonary symptoms whether the injection of omalizumab was sufficient or not ( P<0.05) , but there was o significant difference between the two ( P>0.05). The number of injections was positively correlated with the improvement of shortness of breath/dyspnea ( r=0.225, P<0.05) . The PGIC score of patients with sufficient injection was 3.0(2.0, 3.0) points, and that of patients with insufficient injection was 2.0(2.0, 3.0) points, the difference was not statistically significant ( Z=-0.73, P>0.05). Conclusions:Injection of omalizumab can significantly improve the nasal and pulmonary symptoms of patients. Effective nursing intervention strategies can improve patient compliance,so as to ensure that standardized treatment is of great significance to the improvement of patients′ clinical symptoms.